TRDA · Entrada Therapeutics, Inc. · Documents
Market Cap
$248.42M
Shares
38.94M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-05-19 | 2026-05-18 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-24 | 2026-06-10 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-08 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-06-03 | 2025-05-30 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-25 | 2025-06-11 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-02-24 | — | |
| 8-K | 2025-02-03 | — | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-24 | — | |
| 8-K | 2024-06-24 | — | |
| 8-K | 2024-06-13 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-29 | 2024-06-13 | |
| 8-K | 2024-03-13 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-01-03 | 2023-12-29 | |
| 8-K | 2023-12-06 | 2023-12-05 | |
| 8-K | 2023-11-22 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-11-01 | 2023-10-26 | |
| 8-K | 2023-09-29 | — | |
| 8-K | 2023-09-21 | — | |
| 8-K | 2023-08-10 | 2023-08-04 | |
| 10-K/A | 2023-08-08 | 2022-12-31 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 |
Showing 1–50 of 77 filings
Key facts
CIK
1689375
CUSIP
29384C108
13F (30d)
75 filings
75 filers
Visit website
Investor relations